| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Livingston Robert | Director | C/O AMPHENOL CORPORATION, 358 HALL AVENUE, WALLINGFORD | /s/ Lance E. D'Amico, POA | 06 Feb 2026 | 0001302675 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | APH | Class A Common Stock | Purchase | $1,285,080 | +10,000 | +8% | $128.51 | 135,720 | 05 Feb 2026 | Direct | F1, F2 |
| holding | APH | Restricted Stock | 2,360 | 05 Feb 2026 | Direct |
| Id | Content |
|---|---|
| F1 | The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $128.2928 to $128.7052. |